Department of Internal Medicine, Faculty of Medicine, Lokman Hekim University, Ankara, Turkey.
J Coll Physicians Surg Pak. 2021 Sep;31(9):1064-1068. doi: 10.29271/jcpsp.2021.09.1064.
To determine the effect of vitamin D treatment on platelet counts according to age groups in patients with vitamin D deficiency.
An observational study.
Outpatient Clinics, Department of Internal Medicine, Faculty of Medicine, Lokman Hekim University Hospital, Ankara, Turkey from January 1st to December 31st, 2020.
A total of 1,230 participants, who were treated for vitamin D deficiency after admission to hospital for various reasons, were enrolled. Patients under 18 years of age, having chronic diseases, using medicines affecting platelets and who had 25-hydroxyvitamin D levels above 74.88 nmol/L were excluded from study. Participants were divided into three groups according to ages: 18 to 30 (Group 1), 30 to 50 (Group 2), and greater than 50 years (Group 3). Complete blood count parameters and vitamin D level data before and after vitamin D replacement treatment were compared.
Platelet counts and mean platelet volume levels were found to be significantly lower in participants after vitamin D treatment. Changes in hemoglobin and neutrophil counts were insignificant. Although there was no difference between mean platelet counts and age groups before treatment, significant differences were noted after vitamin D treatment (p=0.004). Correlation between vitamin D levels and changes in platelet levels compared to treatment beginning was found to be significant (r=-0.159, p<0.001).
Vitamin D treatment lowered platelet counts. This may be beneficial in medical conditions such as essential thrombocythemia in which platelet counts are higher than normal, and may help decrease platelet counts. Key Words: Complete blood count, Blood platelet count, Vitamin D.
根据维生素 D 缺乏症患者的年龄组,确定维生素 D 治疗对血小板计数的影响。
观察性研究。
2020 年 1 月 1 日至 12 月 31 日,土耳其安卡拉 Lokman Hekim 大学附属医院内科门诊。
共纳入 1230 名因各种原因住院治疗维生素 D 缺乏症的患者。排除年龄小于 18 岁、患有慢性病、使用影响血小板药物且 25-羟维生素 D 水平高于 74.88nmol/L 的患者。根据年龄将患者分为三组:18-30 岁(组 1)、30-50 岁(组 2)和大于 50 岁(组 3)。比较维生素 D 替代治疗前后的全血细胞计数参数和维生素 D 水平数据。
维生素 D 治疗后,患者的血小板计数和平均血小板体积水平明显降低。血红蛋白和中性粒细胞计数的变化不显著。虽然治疗前血小板计数和年龄组之间没有差异,但维生素 D 治疗后有显著差异(p=0.004)。与治疗开始时相比,维生素 D 水平与血小板水平变化之间的相关性具有统计学意义(r=-0.159,p<0.001)。
维生素 D 治疗降低了血小板计数。在血小板计数高于正常的特发性血小板增多症等医学疾病中,这可能有益,并有助于降低血小板计数。关键词:全血细胞计数,血小板计数,维生素 D。